Gerald Ware, MD
Retina Specialist · Little Rock, ARNPI 1851373484
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,284 of the $2,539 with a category attached, or 90.0%. 17 manufacturers reported payments, led by AbbVie at 25.4% of the total. Reporting peaked in 2024 at $936 and has fallen 57.5% since, to $398 in 2025.
Across 82 payments — averaging $30.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$644
- Alcon$418
- Alimera Sciences, Inc.$370
- Regeneron Healthcare Solutions, Inc.$284
- Mallinckrodt Hospital Products Inc.$196
- Genentech USA, Inc.$156
- plus $471 from 11 others
What the payments were for
- Travel & lodging$1938%
- Food & beverage$2,28490%
- Education$151%
- Gifts$191%
- Other$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $644 |
| Alcon | 2 | $418 |
| Alimera Sciences, Inc. | 9 | $370 |
| Regeneron Healthcare Solutions, Inc. | 11 | $284 |
| Mallinckrodt Hospital Products Inc. | 8 | $196 |
| Genentech USA, Inc. | 8 | $156 |
| Optos, Inc. | 1 | $100 |
| Astellas Pharma US Inc | 4 | $95 |
| Novartis | 5 | $79 |
| ANI Pharmaceuticals, Inc. | 2 | $64 |
| Carl Zeiss Meditec USA, Inc. | 1 | $28 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| Kala Pharmaceuticals, Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Spark Therapeutics, Inc. | 1 | $17 |
| Heidelberg Engineering, Inc. | 1 | $15 |
| Vyera Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- YUTIQ$249
- Iluvien$249
- PANORAMIC OPHTHALMOSCOPE$200
- OZURDEX$131
- OCT OPHTHALMOSCOPE$100
- NFC-700$100
How this compares
Too few retina specialist providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 60 | $3,107 |
| Atropine Sulfate | 56 | $1,996 |
| Ketorolac Tromethamine | 50 | $1,114 |
| Ofloxacin | 36 | $474 |
| Brimonidine Tartrate | 11 | $195 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $194 |
| Latanoprost | 17 | $147 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Little Rock
- Cedric PrattLittle Rock$11K
- Bradley HughesLittle Rock$4K
- Stephen DavisLittle Rock$3K
- John KingLittle Rock$3K
- Muhammad ShamimLittle Rock$2K
- Paul HrubyLittle Rock$1K
- Pedro Soibelmann TetelbomLittle Rock$1K
- William MabreyLittle Rock$825
- Frank LorussoLittle Rock$52
- Rickey MedlockLittle Rock$39
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.